THE RISE OF RETATRUTIDE IN WEIGHT LOSS CLINICS

  Semaglutyd: A Breakthrough Beginning The journey toward effective medical weight loss has taken a transformative turn with the introduction of Semaglutyd. Initially developed as a treatment for type 2 diabetes, this glucagon-like peptide-1 (GLP-1) receptor agonist quickly drew attention for its unexpected and highly beneficial side effect: